

Once-Weekly Exenatide Enhances Weight Loss Maintenance in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled Trial
In this medfyle
Expert commentary by Raghu G. Mirmira, MD, PhD
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the ENDO 2021 and presented by:
Claudia K. Fox, MD, MPH
University of Minnesota, Minneapolis, MN, USA
The content is produced by Infomedica, the official reporting partner of ENDO 2021. The summary text was drafted by Patrick Moore, PhD, and reviewed by Marco Gallo, MD, an independent external expert, and approved by Raghu Mirmira, MD, PhD, the scientific editor of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Raghu G. Mirmira, MD, PhD
University of Chicago, Chicago, IL, USA
About the Expert

Raghu G. Mirmira, MD, PhD
University of Chicago, Chicago, IL, USA
Dr. Mirmira is a physician scientist and endocrinologist. He obtained his MD and PhD degrees from the University of Chicago, completed his residency and endocrinology training at the University of California, San Francisco, then held faculty appointments at the University of Virginia, Indiana University, and the University of Chicago (where he is now). He is the Director of the Translational Research Center, an NIH funded investigator, and conducts a research program focused on the role of the islet in diabetes pathogenesis. He serves as Deputy Editor of the Journal of Clinical Endocrinology and Metabolism.
Disclosures: Dr Mirmira serves on the Scientific Advisory Boards for Veralox Therapeutics, HiberCell, and Sigilon Therapeutics.
References
1. Hales CM, Fryar CD, Carroll MD, et al. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016. JAMA. 2018;319(16):1723-1725.
2. Danielsson P, Kowalski J, Ekblom Ö, Marcus C. Response of severely obese children and adolescents to behavioral treatment. Arch Pediatr Adolesc Med. 2012;166(12):1103-8.
3. Müller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019 Dec;30:72-130.